临床实践
Copyright ©The Author(s) 2017.
世界华人消化杂志. 2017-12-18; 25(35): 3161-3166
在线出版 2017-12-18. doi: 10.11569/wcjd.v25.i35.3161
表1 肿瘤标志物在肝胆良恶性疾病诊断中的比较分析 (mean±SD)
分组nAFP(ng/mL)CEA(ng/mL)CA19-9(U/mL)CA125(U/mL)
健康正常对照组408.17±2.852.42±0.359.44±2.799.08±1.79
肝脏良性疾病组11210.63±4.2612.62±0.69111.26±3.8419.27±2.051
肝脏恶性疾病组75358.03±103.17268.95±15.29282.62±17.94273.73±14.582
胆道良性疾病组677.93±2.1632.05±0.74310.52±2.5339.42±2.063
胆道恶性疾病组16118.67±33.86452.88±8.844302.58±45.02481.18±15.874
表2 肿瘤标志物在肝胆恶性疾病诊断中的诊断价值
指标肝脏恶性疾病诊断
胆道恶性疾病诊断
灵敏度(%)特异度(%)正确率(%)灵敏度(%)特异度(%)正确率(%)
AFP55.3689.1583.4537.3743.8332.48
CEA19.5375.3073.4728.7466.0556.39
CA19-913.5766.8458.8684.7670.0565.59
CA12548.2583.0579.4246.3460.3757.54
AFP+CEA63.29172.18173.21153.62140.05157.741
AFP+CEA+CA19-978.34265.72257.69288.77239.18276.262
AFP+CEA+CA19-9+CA12590.27365.03356.77390.44338.63384.043
表3 肿瘤标志物在肝胆恶性疾病疗效监测中的结果分析 (mean±SD)
指标肝脏恶性疾病 (n = 75)
胆道恶性疾病 (n = 16)
治疗前治疗后治疗前治疗后
AFP(ng/mL)358.03±103.17157.37±34.161126.37±34.3873.93±7.832
CEA(ng/mL)68.95±15.2936.37±5.84153.27±9.0434.04±5.722
CA19-9(U/mL)82.62±17.9442.83±7.631306.36±46.83142.37±38.532
CA125(U/mL)73.73±14.5861.03±10.63181.47±16.0536.38±7.722

引文著录: 周常富, 纪金星. 四种常见肿瘤标记物联合检测在肝胆系统良恶性疾病中的临床价值. 世界华人消化杂志 2017; 25(35): 3161-3166